Takeda Pharmaceutical Company Limited (TAK) stock is nearly perfect except the valuation

The closing price of Takeda Pharmaceutical Company Limited (NYSE: TAK) was $16.08 for the day, up 1.07% from the previous closing price of $15.91. In other words, the price has increased by $+0.17 from its previous closing price. On the day, 2359959 shares were traded. TAK stock price reached its highest trading level at $16.08 during the session, while it also had its lowest trading level at $15.84.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



Our analysis of TAK’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.90. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.63.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cowen on July 19, 2022, Upgraded its rating to Outperform and sets its target price to $24 from $21 previously.

Valuation Measures:

As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 311.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77 while its Price-to-Book (P/B) ratio in mrq is 1.10.

Stock Price History:

Over the past 52 weeks, TAK has reached a high of $16.30, while it has fallen to a 52-week low of $12.28. The 50-Day Moving Average of the stock is 15.81, while the 200-Day Moving Average is calculated to be 14.38.

Shares Statistics:

TAK traded an average of 2.81M shares per day over the past three months and 2.58M shares per day over the past ten days. A total of 3.11B shares are outstanding, with a floating share count of 3.11B. Shares short for TAK as of Jan 12, 2023 were 8.73M with a Short Ratio of 5.03M, compared to 7.21M on Dec 14, 2022.

Dividends & Splits

With its trailing 12-month dividend rate of 180.00, TAK has a forward annual dividend rate of 1.06. Against a Trailing Annual Dividend Yield of 1,131.36%, it implies a Forward Annual Dividend Yield of 4.09%. The stock’s 5-year Average Dividend Yield is 4.64.

Earnings Estimates

The firm’s stock currently is rated by 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.